Bond Biosciences
PrivateLast Round
Seed Round
Apr 1, 2026
Total Funding Raised
$18.96M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bond Biosciences operates in Healthcare & Life Sciences and is based in Parkville, Missouri. Its latest recorded funding round was an Early Funding round in September 2024.
Bond Biosciences is a biopharmaceutical company that discovers and develops first-in-class non-absorbed oral therapeutics that bind excess ions locally in the gastrointestinal tract to treat or prevent human disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bond Biosciences Comparables
Compare Bond Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmacosmos A/S | 71% | |
| Chiesi Farmaceutici S.p.A. | 67% | |
| Novartis | 66% |
For institutional investors. Book with your work email.
Bond Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 1, 2026 | ||||
| Early Funding | Sep 6, 2024 | ||||
| Series B | Jan 25, 2022 | ||||
| Series B | Dec 21, 2021 | ||||
| Grant | Aug 1, 2021 | ||||
Series A | Mar 30, 2021 |
For institutional investors. Book with your work email.
Bond Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioGenerator Ventures | Series A |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Collage Venture Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 36% MoM, reaching 4K.
- Jul 25, 2026
Monthly visitors increased 53% MoM, reaching 2.9K.
For institutional investors. Book with your work email.
Bond Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bond Biosciences's valuation, stock price, and market status.
Is Bond Biosciences a public or private company?
Bond Biosciences is a private company.
What is the current stock price of Bond Biosciences?
Bond Biosciences is a private company, so its shares have no public market price. Caplight tracks Bond Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bond Biosciences worth (valuation)?
Valuation information for Bond Biosciences is not publicly available.
Can I buy Bond Biosciences stock?
Bond Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bond Biosciences's last funding round?
Bond Biosciences's most recent funding round was Seed Round on April 1, 2026.
Who are the main investors in Bond Biosciences?
Key investors in Bond Biosciences include Collage Venture Partners.
Will Bond Biosciences IPO soon?
No public IPO plans have been announced for Bond Biosciences.
How can I track Bond Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Bond Biosciences's shares on secondary markets.